[Dose finding study of cefepime for chronic respiratory infections]

Autor: Atsushi SAITO, Yoshiteru SHIGENO, Yuei IRABU, Hiroshi FUKUHARA, Akira SAITO, Ichiro NAKAYAMA, Yohmei HIRAGA, Mitsuhide OHMICHI, Kotaro OIZUMI, Akira WATANABE, Izumi HAYASHI, Kaoru SHIMADA, Yasuyuki SANO, Yasuo ARAI, Naohito SUZUKI, Hiroyuki KOBAYASHI, Hiroshi OSHITANI, Hisashi INOUE, Jingoro SHIMADA, Kohya SHIBA, Masanobu KAJI, Osamu SAKAI, Hiroichi TANIMOTO, Koichiro NAKATA, Yoshitaka NAKAMORI, Naohiko CHONABAYASHI, Masayuki NOGUCHI, Fumio MATSUMOTO, Iwao SAKURAI, Shigeki ODAGIRI, Masanori MATSUMURA, Kaneo SUZUKI, Toshiyuki YAMAMOTO, Kanzo SUZUKI, Satoru ADACHI, Nobuhiro NARITA, Masayoshi SAWAKI, Keiichi MIKASA, Fumio MIKI, Rinzo SOEJIMA, Yoshihito NIKI, Jiro HINO, Masaru SUMI, Masashi KIMURA, Osamu TATARA, Toshiharu MATSUSHIMA, Masayoshi KAWANISHI, Kohei HARA, Keizo YAMAGUCHI, Shigeru KOHNO, Takahisa ARAMAKI, Yoshito TANAKA, Keizo KUDO, Masanori IWAMOTO, Hiroshi MUKAI, Toru ISHINO, Tsuneo FUJIWARA, Keizo MATSUMOTO, Kazunori OISHI, Masaru NASU, Yoichiro GOTO, Jun GOTO, Takayoshi TASHIRO, Nobuya OGAWA, Nobuchika KUSANO

Publikováno v: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 66(7)

In order to determine the optimal dose of cefepime (CFPM) for respiratory tract infections, a dose finding study was conducted in patients with chronic respiratory tract infections, and the clinical properties of the drugs were compared with those of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::739976be2d9fa3f896437118adfe63be
https://pubmed.ncbi.nlm.nih.gov/1431363